Anna Potamianou

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

María‐Victoria Mateos, Katja Weisel, Valerio De Stefano et al. · Leukemia · 2022 · 225 citations · Full text

Relapsed/refractory Mm, Cancer Management, Immunology +18

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Hartmut Goldschmidt, H M Lokhorst, E K et al. · Leukemia · 2017 · 197 citations · Full text

Hematological Malignancy, Oncology, Hematology +7

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

G. Stathopoulos, K. Syrigos, Gerasimos Aravantinos et al. · British Journal of Cancer · 2006 · 196 citations · Full text

Urology, Pancreatic Cancer, Gemcitabine Monotherapy +15

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

Pierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti et al. · Leukemia · 2018 · 159 citations · Full text

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial

Dimitriοs Mavroudis, Nikolaos Malamos, A. Alexopoulos et al. · Annals of Oncology · 1999 · 94 citations · Full text

Salvage Chemotherapy, Breast Oncology, Oncology +6